I.V. Hall is Chief Operating Officer of Kuros Biosciences and brings more than 30 years of experience in the medical device industry to the Bonebridge Board of Directors. Prior to Kuros, he spent 27 years in global leadership roles with Synthes and Johnson & Johnson and was CEO and Managing Director of Next Science, LLC. He serves on the Technology Transfer Board of the AO Foundation as well as on the advisory board at Clemson University.
I.V. Hall’s perspective will be especially valuable as we continue to scale our portfolio and expand our footprint in the USA: “His insights into the US market have already been extremely valuable over the last few months, and it’s a privilege to have him on the Board of Directors going forward,” says Prof. Christian Gerber, Chairman of the Board. “I’m convinced that this addition comes exactly at the right time as we continue to advance our strategic initiatives and build momentum in the United States.”
“I’m very happy to be on board and support Bonebridge’s mission of promoting simplicity in orthopaedic trauma,” I.V. Hall says on his appointment. “I look forward to working with the great people at Bonebridge and contributing to the company’s future success.”
With the appointment of I.V. Hall, we continue to strengthen our governance structure and reinforce our commitment to reduce complexity in orthopaedic trauma.